Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

GPC Consolidates Drug Discovery Activities to Munich Site

  • GPC Biotech is consolidating its drug discovery efforts, and the programs currently being managed in Waltham, MA will be moved to its Munich location. Th company's Waltham facility will be closed and staff will be reduced by approximately 16%. The company is continuing to build its clinical development and commercialization groups based in Princeton, NJ.

    The move comes after the 2005 acquisition of the assets and hiring of many research scientists of Munich-based Axxima Pharmaceuticals, as well as the ending of a collaboration with Altana Pharma in Waltham.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »